Literature DB >> 30809798

P-selectin plays a role in haem-induced acute lung injury in sickle mice.

Samit Ghosh1,2, Bethany Flage2, Frances Weidert2, Solomon F Ofori-Acquah1,2,3.   

Abstract

Entities:  

Keywords:  P-selectin; acute chest syndrome; haem; sickle cell disease

Mesh：

Substances：

Year:  2019        PMID： 30809798      PMCID： PMC6860014          DOI： 10.1111/bjh.15807

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  P-selectin mediates the adhesion of sickle erythrocytes to the endothelium.

Authors:  N M Matsui; L Borsig; S D Rosen; M Yaghmai; A Varki; S H Embury
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

2.  GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice.

Authors:  Jungshan Chang; John T Patton; Arun Sarkar; Beat Ernst; John L Magnani; Paul S Frenette
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

Review 3.  Pulmonary complications of sickle cell disease.

Authors:  Mark T Gladwin; Elliott Vichinsky
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

4.  Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease.

Authors:  E P Vichinsky; L A Styles; L H Colangelo; E C Wright; O Castro; B Nickerson
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

5.  Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.

Authors:  E P Vichinsky; L D Neumayr; A N Earles; R Williams; E T Lennette; D Dean; B Nickerson; E Orringer; V McKie; R Bellevue; C Daeschner; E A Manci
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

6.  The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo.

Authors:  Stephen H Embury; Neil M Matsui; Sahana Ramanujam; Tanya N Mayadas; Constance T Noguchi; Bhalchandra A Diwan; Narla Mohandas; Anthony T W Cheung
Journal:  Blood       Date:  2004-07-22       Impact factor: 22.113

7.  Rapidly progressive acute chest syndrome in individuals with sickle cell anemia: a distinct acute chest syndrome phenotype.

Authors:  Shruti Chaturvedi; Djamila L Ghafuri; Jeffrey Glassberg; Adetola A Kassim; Mark Rodeghier; Michael R DeBaun
Journal:  Am J Hematol       Date:  2016-10-03       Impact factor: 10.047

8.  Extracellular hemin crisis triggers acute chest syndrome in sickle mice.

Authors:  Samit Ghosh; Olufolake Adetoro Adisa; Prasanthi Chappa; Fang Tan; Kesmic Ann Jackson; David Robert Archer; Solomon Fiifi Ofori-Acquah
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

9.  Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.

Authors:  Kenneth I Ataga; Abdullah Kutlar; Julie Kanter; Darla Liles; Rodolfo Cancado; João Friedrisch; Troy H Guthrie; Jennifer Knight-Madden; Ofelia A Alvarez; Victor R Gordeuk; Sandra Gualandro; Marina P Colella; Wally R Smith; Scott A Rollins; Jonathan W Stocker; Russell P Rother
Journal:  N Engl J Med       Date:  2016-12-03       Impact factor: 91.245

10.  Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.

Authors:  John D Belcher; Chunsheng Chen; Julia Nguyen; Liming Milbauer; Fuad Abdulla; Abdu I Alayash; Ann Smith; Karl A Nath; Robert P Hebbel; Gregory M Vercellotti
Journal:  Blood       Date:  2013-11-25       Impact factor: 22.113
  10 in total
  7 in total

1.  Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events?

Authors:  Marilyn J Telen
Journal:  Blood Adv       Date:  2020-07-28

2.  Cortactin loss protects against hemin-induced acute lung injury in sickle cell disease.

Authors:  Nicole M Jones; Justin R Sysol; Sunit Singla; Patricia Smith; George E Sandusky; Huashan Wang; Viswanathan Natarajan; Steven M Dudek; Roberto F Machado
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-05-03       Impact factor: 6.011

3.  Redox Signaling in Sickle Cell Disease.

Authors:  Deirdre Nolfi-Donegan; Tirthadipa Pradhan-Sundd; Kirkwood A Pritchard; Cheryl A Hillery
Journal:  Curr Opin Physiol       Date:  2019-05-02

4.  Integrin VLA-4 as a PET imaging biomarker of hyper-adhesion in transgenic sickle mice.

Authors:  Lydia A Perkins; Lea Nyiranshuti; Lynda Little-Ihrig; Joseph D Latoche; Kathryn E Day; Qin Zhu; Sina Tavakoli; Prithu Sundd; Enrico M Novelli; Carolyn J Anderson
Journal:  Blood Adv       Date:  2020-09-08

5.  Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.

Authors:  Francesca Vinchi; Richard Sparla; Sara T Passos; Richa Sharma; S Zebulon Vance; Hala S Zreid; Hesham Juaidi; Deepa Manwani; Karina Yazdanbakhsh; Vijay Nandi; André M N Silva; Anand R Agarvas; Eitan Fibach; John D Belcher; Gregory M Vercellotti; Husam Ghoti; Martina U Muckenthaler
Journal:  Br J Haematol       Date:  2021-03-15       Impact factor: 6.998

Review 6.  The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.

Authors:  Oluwabukola T Gbotosho; Maria G Kapetanaki; Gregory J Kato
Journal:  Front Immunol       Date:  2021-01-27       Impact factor: 7.561

Review 7.  Significance of Heme and Heme Degradation in the Pathogenesis of Acute Lung and Inflammatory Disorders.

Authors:  Stefan W Ryter
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.